Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study

Hayashi, Tomoyuki; Yamashita, Taro; Terashima, Takeshi; Suda, Tsuyoshi; Okada, Hikari; Asahina, Yoshiro; Hayashi, Takehiro; Hara, Yasumasa; Nio, Kouki; Sunagozaka, Hajime; Takatori, Hajime; Arai, Kuniaki; Sakai, Yoshio; Yamashita, Tatsuya; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi

doi:10.1186/s12885-017-3889-x

BMC Cancer

Article metrics
Last updated: Thu, 18 Apr 2024 7:49:51 Z

Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study

Access & Citations

2273

Article Accesses
22

Web of Science
19

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com